Jump to content
 







Main menu
    


Navigation  


●Main page
 ●Contents
 ●Current events
 ●Random article
 ●About Wikipedia
 ●Contact us
 ●Donate
  



Contribute  


●Help
 ●Learn to edit
 ●Community portal
 ●Recent changes
 ●Upload file
  







Search  

































●Create account

●Log in
 









●Create account
 ● Log in
  



Pages for logged out editors learn more  


●Contributions
 ●Talk
  


















Contents

   



(Top)
  


1 See also  




2 References  













Batoprazine






●فارسی
 ●日本語
 ●Српски / srpski
 ●Srpskohrvatski / српскохрватски
  
Edit links
  








●Article
 ●Talk
  
















●Read
 ●Edit
 ●View history
  







Tools
    


Actions  


●Read
 ●Edit
 ●View history
  



General  


●What links here
 ●Related changes
 ●Upload file
 ●Special pages
 ●Permanent link
 ●Page information
 ●Cite this page
 ●Get shortened URL
 ●Download QR code
 ●Wikidata item
  



Print/export  


●Download as PDF
 ●Printable version
  



In other projects  


●Wikimedia Commons
  















Appearance
    

 





From Wikipedia, the free encyclopedia
  

Batoprazine
Clinical data
Other names8-(1-piperazinyl)coumarin;
8-(1-piperazinyl)-2H-
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers

  • 8-(piperazin-1-yl)-2H-chromen-2-one

CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H14N2O2
Molar mass230.267 g·mol−1
3D model (JSmol)

  • O=C/2Oc1c(cccc1\C=C\2)N3CCNCC3

  • InChI=1S/C13H14N2O2/c16-12-5-4-10-2-1-3-11(13(10)17-12)15-8-6-14-7-9-15/h1-5,14H,6-9H2 checkY

  • Key:MTYYDFXUUJQQRS-UHFFFAOYSA-N checkY

 ☒NcheckY (what is this?)  (verify)

Batoprazine is a drug of the phenylpiperazine class which has been described as a serenic or antiaggressive agent.[1][2] It acts as a 5-HT1A and 5-HT1B receptor agonist.[2][3] It is closely related to eltoprazine, fluprazine, and naphthylpiperazine, of which possess similar actions and effects.[3]

See also[edit]

References[edit]

  1. ^ Olivier B (December 2004). "Serotonin and aggression". Annals of the New York Academy of Sciences. 1036: 382–92. doi:10.1196/annals.1330.022. PMID 15817750. S2CID 45595253.
  • ^ a b Olivier B, van Oorschot R (December 2005). "5-HT1B receptors and aggression: a review". European Journal of Pharmacology. 526 (1–3): 207–17. doi:10.1016/j.ejphar.2005.09.066. PMID 16310769.
  • ^ a b Gommans J, Hijzen TH, Maes RA, Olivier B (1997). "Discriminative stimulus properties of eltoprazine". Life Sciences. 61 (1): 11–9. doi:10.1016/S0024-3205(97)00352-4. PMID 9200664.

    • Retrieved from "https://en.wikipedia.org/w/index.php?title=Batoprazine&oldid=1166938774"
    Categories: 
    ●Drugs not assigned an ATC code
     ●N-(2-methoxyphenyl)piperazines
     ●Serotonin receptor agonists
     ●Coumarin drugs
     ●1-Piperazinyl compounds
     Hidden categories: 
    ●Articles with short description
     ●Short description matches Wikidata
     ●Drugs with non-standard legal status
     ●Articles with changed CASNo identifier
     ●Articles with changed EBI identifier
     ●Chemical pages without DrugBank identifier
     ●Articles without KEGG source
     ●Drugboxes which contain changes to verified fields
      


    ●This page was last edited on 24 July 2023, at 18:18 (UTC).
    ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


    ●Privacy policy
    ●About Wikipedia
    ●Disclaimers
    ●Contact Wikipedia
    ●Code of Conduct
    ●Developers
    ●Statistics
    ●Cookie statement
    ●Mobile view


    Wikimedia Foundation
    Powered by MediaWiki